NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE248155 Query DataSets for GSE248155
Status Public on Oct 01, 2024
Title Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Nov 17, 2023
Last update date Oct 01, 2024
Contact name Chia-Lang Hsu
E-mail(s) chialanghsu@ntuh.gov.tw
Organization name National Taiwan University Hospital
Department Department of Medical Research
Street address No. 7, Zhongshan S. Rd.
City Taipei
ZIP/Postal code 100
Country Taiwan
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (31)
GSM7906479 HNSCC mouse models with treatment of vehicle (#1)
GSM7906480 HNSCC mouse models with treatment of vehicle (#2)
GSM7906481 HNSCC mouse models with treatment of vehicle (#3)
This SuperSeries is composed of the following SubSeries:
GSE248153 Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma [HNSCC_model]
GSE248154 Effect of regorafenib, anti-PD1, and anti-CD40 agonist in Head and Neck Squamous Cell Carcinoma [4NQO_model]
Relations
BioProject PRJNA1041830

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary data files not provided
SRA Run SelectorHelp
| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap